Skip to main content
Log in

The Present and Future Use of β-Blockers

  • Section 1A: Hypertension
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The current state of knowledge about β-blockers in treating hypertension and their comparative pharmacology is reviewed. Some new developments in antihypertensive therapy, such as converting-enzyme inhibitors and calcium antagonistic drugs are discussed and their place vis-a-vis the β-blockers analysed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barbarino, A. and De Marinis, L.: Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone and thyrotropin-releasing hormone-induced pituitary hormone release in normal subjects. Journal of Clinical Endocrinology and Metabolism 51: 749–754 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Bühler, F.R.; Burkhart, F.; Lutold, B.E.; Kung, M.; Marbet, G. and Pfisterer, M.: Antihypertensive beta-blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. American Journal of Cardiology 35: 653–669 (1975).

    Article  Google Scholar 

  • Campbell, W.B.; Johnson, A.R.; Callahan, K.S. and Graham, R.M.: Anti-platelet activity of beta-adrenergic antagonists: Inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancet 2: 1382–1384 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Day, J.L.; Metcalfe, J. and Simpson, C.N.: Adrenergic mechanisms in control of plasma lipid concentrations. British Medical Journal 284, 1145–1148 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Guazzi, M.; Olivari, M.T.; Polese, A.; Fiorentini, C.; Magrini, F. and Moruzzi, P.: Nifedipine, a new antihypertensive with rapid action. Clinical Pharmacology and Therapeutics 22: 528–532 (1977).

    PubMed  CAS  Google Scholar 

  • Jennings, G.L.; Esler, M.D. and Korner, P.I.: Effect of prolonged treatment on hemodynamics of essential hypertension before and after autonomic block. Lancet 2: 166–169 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Kaplan, N.M.: Clinical Hypertension (3rd ed.) pp. 98–192 (Williams and Wilkins, Baltimore 1982).

    Google Scholar 

  • Lindemann, J.P.; Bailey, J.C. and Watanabe, A.M.: Potential biochemical mechanisms for regulation of the slow inward current: Theoretical basis for drug action. American Heart Journal 103: 746–755 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Lund-Johansen, P.: Hemodynamic consequences of long-term beta-blocker therapy: A 5-year follow-up study of atenolol. Journal of Cardiovascular Pharmacology 1: 487–495 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Meier, J.: Beta-adrenoceptor-blocking agents: Pharmacokinetic differences and their clinical implications illustrated on pindolol. Cardiology 64(Suppl. 1): 1–13 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Rubin, R.P.: Actions of calcium antagonists of secretory cells: in Weiss, G.B. (Ed.) New Perspectives on Calcium Antagonists, pp. 147–158 (American Physiology Society, Bethesda, Maryland 1981).

    Google Scholar 

  • Seedat, Y.K.: Trial of atenolol and chlorthalidone for hypertension in black South Africans. British Medical Journal 281: 1241–1245 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Swales, J.D.; Bing, R.G.; Heagerty, A.; Pohl, J.E.F.; Russell, G.I. and Thurston, H.: Treatment of refractory hypertension. Lancet 1: 894–896 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Watson, R.D.S.; Stallard, T.J. and Littler, W.A.: Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability. Lancet 1: 1210–1213 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Wilcox, R.G.: Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. British Medical Journal 2: 383–385 (1978).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaplan, N.M. The Present and Future Use of β-Blockers. Drugs 25 (Suppl 2), 1–4 (1983). https://doi.org/10.2165/00003495-198300252-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198300252-00002

Keywords

Navigation